Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lubert-Adler Partners is a real estate private equity firm headquartered in Philadelphia, Pennsylvania, founded in 1997 by Ira Lubert and Dean Adler. While primarily a real estate investment firm, it plays a significant role in the life sciences sector by developing and managing specialized laboratory and research infrastructure. The firm is well-known for large-scale redevelopment projects, such as the Budd Bioworks campus, which converts industrial space into high-tech cGMP manufacturing and lab facilities for biotech companies. Lubert-Adler manages over $6.5 billion in equity assets and focuses on opportunistic investments across various property types, including the growing demand for life science real estate.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lubert-Adler Partners.